Global Cancer Gene Therapy Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Cancer Gene Therapy Revenue
• 1.4 Market by Type
  • 1.4.1 Global Cancer Gene Therapy Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Oncolytic Virotherapy
  • 1.4.3 Gene Transfer
  • 1.4.4 Gene-Induced Immunotherapy
• 1.5 Market by Application
  • 1.5.1 Global Cancer Gene Therapy Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals
  • 1.5.3 Diagnostics Centers
  • 1.5.4 Research Institutes
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Cancer Gene Therapy Market Perspective (2015-2026)
• 2.2 Global Cancer Gene Therapy Growth Trends by Regions
  • 2.2.1 Cancer Gene Therapy Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Cancer Gene Therapy Historic Market Share by Regions (2015-2020)
  • 2.2.3 Cancer Gene Therapy Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Cancer Gene Therapy Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Cancer Gene Therapy Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Cancer Gene Therapy Players by Market Size
  • 3.1.1 Global Top Cancer Gene Therapy Players by Revenue (2015-2020)
  • 3.1.2 Global Cancer Gene Therapy Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Cancer Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Cancer Gene Therapy Market Concentration Ratio
  • 3.2.1 Global Cancer Gene Therapy Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Cancer Gene Therapy Revenue in 2019
• 3.3 Cancer Gene Therapy Key Players Head office and Area Served
• 3.4 Key Players Cancer Gene Therapy Product Solution and Service
• 3.5 Date of Enter into Cancer Gene Therapy Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Cancer Gene Therapy Historic Market Size by Type (2015-2020)
• 4.2 Global Cancer Gene Therapy Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Cancer Gene Therapy Market Size by Application (2015-2020)
• 5.2 Global Cancer Gene Therapy Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Cancer Gene Therapy Market Size (2015-2020)
• 6.2 Cancer Gene Therapy Key Players in North America (2019-2020)
• 6.3 North America Cancer Gene Therapy Market Size by Type (2015-2020)
• 6.4 North America Cancer Gene Therapy Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Cancer Gene Therapy Market Size (2015-2020)
• 7.2 Cancer Gene Therapy Key Players in Europe (2019-2020)
• 7.3 Europe Cancer Gene Therapy Market Size by Type (2015-2020)
• 7.4 Europe Cancer Gene Therapy Market Size by Application (2015-2020)

8 China

• 8.1 China Cancer Gene Therapy Market Size (2015-2020)
• 8.2 Cancer Gene Therapy Key Players in China (2019-2020)
• 8.3 China Cancer Gene Therapy Market Size by Type (2015-2020)
• 8.4 China Cancer Gene Therapy Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Cancer Gene Therapy Market Size (2015-2020)
• 9.2 Cancer Gene Therapy Key Players in Japan (2019-2020)
• 9.3 Japan Cancer Gene Therapy Market Size by Type (2015-2020)
• 9.4 Japan Cancer Gene Therapy Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Cancer Gene Therapy Market Size (2015-2020)
• 10.2 Cancer Gene Therapy Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Cancer Gene Therapy Market Size by Type (2015-2020)
• 10.4 Southeast Asia Cancer Gene Therapy Market Size by Application (2015-2020)

11 India

• 11.1 India Cancer Gene Therapy Market Size (2015-2020)
• 11.2 Cancer Gene Therapy Key Players in India (2019-2020)
• 11.3 India Cancer Gene Therapy Market Size by Type (2015-2020)
• 11.4 India Cancer Gene Therapy Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Cancer Gene Therapy Market Size (2015-2020)
• 12.2 Cancer Gene Therapy Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Cancer Gene Therapy Market Size by Type (2015-2020)
• 12.4 Central & South America Cancer Gene Therapy Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Adaptimmune
  • 13.1.1 Adaptimmune Company Details
  • 13.1.2 Adaptimmune Business Overview
  • 13.1.3 Adaptimmune Cancer Gene Therapy Introduction
  • 13.1.4 Adaptimmune Revenue in Cancer Gene Therapy Business (2015-2020))
  • 13.1.5 Adaptimmune Recent Development
• 13.2 Bluebird bio
  • 13.2.1 Bluebird bio Company Details
  • 13.2.2 Bluebird bio Business Overview
  • 13.2.3 Bluebird bio Cancer Gene Therapy Introduction
  • 13.2.4 Bluebird bio Revenue in Cancer Gene Therapy Business (2015-2020)
  • 13.2.5 Bluebird bio Recent Development
• 13.3 Celgene
  • 13.3.1 Celgene Company Details
  • 13.3.2 Celgene Business Overview
  • 13.3.3 Celgene Cancer Gene Therapy Introduction
  • 13.3.4 Celgene Revenue in Cancer Gene Therapy Business (2015-2020)
  • 13.3.5 Celgene Recent Development
• 13.4 Shanghai Sunway Biotech
  • 13.4.1 Shanghai Sunway Biotech Company Details
  • 13.4.2 Shanghai Sunway Biotech Business Overview
  • 13.4.3 Shanghai Sunway Biotech Cancer Gene Therapy Introduction
  • 13.4.4 Shanghai Sunway Biotech Revenue in Cancer Gene Therapy Business (2015-2020)
  • 13.4.5 Shanghai Sunway Biotech Recent Development
• 13.5 Shenzhen SiBiono GeneTech
  • 13.5.1 Shenzhen SiBiono GeneTech Company Details
  • 13.5.2 Shenzhen SiBiono GeneTech Business Overview
  • 13.5.3 Shenzhen SiBiono GeneTech Cancer Gene Therapy Introduction
  • 13.5.4 Shenzhen SiBiono GeneTech Revenue in Cancer Gene Therapy Business (2015-2020)
  • 13.5.5 Shenzhen SiBiono GeneTech Recent Development
• 13.6 SynerGene Therapeutics
  • 13.6.1 SynerGene Therapeutics Company Details
  • 13.6.2 SynerGene Therapeutics Business Overview
  • 13.6.3 SynerGene Therapeutics Cancer Gene Therapy Introduction
  • 13.6.4 SynerGene Therapeutics Revenue in Cancer Gene Therapy Business (2015-2020)
  • 13.6.5 SynerGene Therapeutics Recent Development
• 13.7 Altor BioScience
  • 13.7.1 Altor BioScience Company Details
  • 13.7.2 Altor BioScience Business Overview
  • 13.7.3 Altor BioScience Cancer Gene Therapy Introduction
  • 13.7.4 Altor BioScience Revenue in Cancer Gene Therapy Business (2015-2020)
  • 13.7.5 Altor BioScience Recent Development
• 13.8 Amgen
  • 13.8.1 Amgen Company Details
  • 13.8.2 Amgen Business Overview
  • 13.8.3 Amgen Cancer Gene Therapy Introduction
  • 13.8.4 Amgen Revenue in Cancer Gene Therapy Business (2015-2020)
  • 13.8.5 Amgen Recent Development
• 13.9 Argenx
  • 13.9.1 Argenx Company Details
  • 13.9.2 Argenx Business Overview
  • 13.9.3 Argenx Cancer Gene Therapy Introduction
  • 13.9.4 Argenx Revenue in Cancer Gene Therapy Business (2015-2020)
  • 13.9.5 Argenx Recent Development
• 13.10 BioCancell
  • 13.10.1 BioCancell Company Details
  • 13.10.2 BioCancell Business Overview
  • 13.10.3 BioCancell Cancer Gene Therapy Introduction
  • 13.10.4 BioCancell Revenue in Cancer Gene Therapy Business (2015-2020)
  • 13.10.5 BioCancell Recent Development
• 13.11 GlaxoSmithKline
  • 10.11.1 GlaxoSmithKline Company Details
  • 10.11.2 GlaxoSmithKline Business Overview
  • 10.11.3 GlaxoSmithKline Cancer Gene Therapy Introduction
  • 10.11.4 GlaxoSmithKline Revenue in Cancer Gene Therapy Business (2015-2020)
  • 10.11.5 GlaxoSmithKline Recent Development
• 13.12 Merck
  • 10.12.1 Merck Company Details
  • 10.12.2 Merck Business Overview
  • 10.12.3 Merck Cancer Gene Therapy Introduction
  • 10.12.4 Merck Revenue in Cancer Gene Therapy Business (2015-2020)
  • 10.12.5 Merck Recent Development
• 13.13 OncoGenex Pharmaceuticals
  • 10.13.1 OncoGenex Pharmaceuticals Company Details
  • 10.13.2 OncoGenex Pharmaceuticals Business Overview
  • 10.13.3 OncoGenex Pharmaceuticals Cancer Gene Therapy Introduction
  • 10.13.4 OncoGenex Pharmaceuticals Revenue in Cancer Gene Therapy Business (2015-2020)
  • 10.13.5 OncoGenex Pharmaceuticals Recent Development
• 13.14 Transgene
  • 10.14.1 Transgene Company Details
  • 10.14.2 Transgene Business Overview
  • 10.14.3 Transgene Cancer Gene Therapy Introduction
  • 10.14.4 Transgene Revenue in Cancer Gene Therapy Business (2015-2020)
  • 10.14.5 Transgene Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer